COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL

Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study. 160 patients received carvedilol and 160 patients – metoprolol. Both randomized...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
Формат: Artigo
Язык:Inglês
Опубликовано: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Серии:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Предметы:
arterial hypertension
overweight
obesity
beta-blockers
carvedilol
metoprolol
Online-ссылка:https://www.rpcardio.com/jour/article/view/617
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы